Winter Haven, FL 33810
To determine the safety and tolerability of subjects with Fibromyalgia and moderate to severe renal dysfunction during 13 weeks of renally adjusted dosing of DS-5565 compared to placebo....
| All trademarks are property of their legal owners. | All Rights Reserved
ClinicalConnection.com is a resource that provides information on clinical trials conducted worldwide.
ClinicalConnection.com does not conduct or endorse clinical trials. Please consult your physician before participating.
© All Rights Reserved.
Terms of Service